Trials / Completed
CompletedNCT04880252
Neuropsychological Indicators of SCD Progression
In Individuals With Subjective Cognitive Decline, Age, Memory and Action Speed Scores at Baseline Predict Progression to Cognitive Impairment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Some patients with subjective cognitive decline (SCD) progress to neurocognitive disorders (NCD), whereas others remain stable; however, the neuropsychological determinants of this progression have not been identified. The investigators objective was to examine baseline neuropsychological indicators that could discriminate between people in whom the SCD progressed to a mild or major NCD and people in whom the SCD remained stable. The investigators retrospectively included patients consulting for SCD at a university medical center's memory center (Amiens, France) and who had undergone three or more neuropsychological assessments at least 6 months apart. The relationship between domain-specific scores and the global cognitive score (GCS, as a function of final status (stable SCD vs. progression toward a mild or major NCD)) was examined using a generalized linear mixed model.
Conditions
- Biomarkers
- Cognitive Assessment
- Cognitive Decline
- Neurocognitive Disorders
- Neurodegenerative Diseases
- Subjective Cognitive Decline
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2021-05-10
- Last updated
- 2021-05-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04880252. Inclusion in this directory is not an endorsement.